Code of Massachusetts Regulations
958 CMR - HEALTH POLICY COMMISSION
Title 958 CMR 12.00 - Drug Pricing Review
- Section 12.01 - Scope and Purpose
- Section 12.02 - Definitions
- Section 12.03 - Notice of Identification by the Executive Office
- Section 12.04 - Standard Reporting Form, Requests for Information, and Attestation Form
- Section 12.05 - Public Notice and Stakeholder Input
- Section 12.06 - Identification of a Proposed Value
- Section 12.07 - Identification of a Proposed Supplemental Rebate
- Section 12.08 - Determination of Potentially Unreasonable or Excessive Pricing
- Section 12.09 - Determination of Unreasonable or Excessive Pricing
- Section 12.10 - Further Negotiations with the Executive Office
- Section 12.11 - Information Provided by the Executive Office in Connection with the Referral
- Section 12.12 - Confidentiality
- Section 12.13 - Penalties
- Section 12.14 - Applicability to Individual Patients
- Section 12.15 - Severability
Current through Register 1531, September 27, 2024
REGULATORY AUTHORITY
958 CMR 12.00: M.G.L. c. 6D, § 8A and M.G.L. c. 118E, § 12A.
Disclaimer: These regulations may not be the most recent version. Massachusetts may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
